Interestingly, Konopleva et al. showed that MEK inhibitors such as PD0325901 and CI-1040, which are capable of inhibiting the activation of ERK, successfully suppressed Mcl-1 expression in Leukemia cells [36]. Here, MAP2K7 is linked to leukemia.